Oral non‐steroidal anti‐inflammatory drugs versus other oral analgesic agents for acute soft tissue injury
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Oral Non‐steroidal Anti‐inflammatory Drugs Versus Other Oral Analgesic Agents for Acute Soft Tissue Injury." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/432983/all/Oral_non‐steroidal_anti‐inflammatory_drugs_versus_other_oral_analgesic_agents_for_acute_soft_tissue_injury.
Oral non‐steroidal anti‐inflammatory drugs versus other oral analgesic agents for acute soft tissue injury. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/432983/all/Oral_non‐steroidal_anti‐inflammatory_drugs_versus_other_oral_analgesic_agents_for_acute_soft_tissue_injury. Accessed February 16, 2025.
Oral non‐steroidal anti‐inflammatory drugs versus other oral analgesic agents for acute soft tissue injury. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/432983/all/Oral_non‐steroidal_anti‐inflammatory_drugs_versus_other_oral_analgesic_agents_for_acute_soft_tissue_injury
Oral Non‐steroidal Anti‐inflammatory Drugs Versus Other Oral Analgesic Agents for Acute Soft Tissue Injury [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 February 16]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/432983/all/Oral_non‐steroidal_anti‐inflammatory_drugs_versus_other_oral_analgesic_agents_for_acute_soft_tissue_injury.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Oral non‐steroidal anti‐inflammatory drugs versus other oral analgesic agents for acute soft tissue injury
ID - 432983
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/432983/all/Oral_non‐steroidal_anti‐inflammatory_drugs_versus_other_oral_analgesic_agents_for_acute_soft_tissue_injury
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -